Concurrent with our early studies of tmem230 regulation in an animal model, gene mutations in human patients were identified, suggesting a high risk of age-dependent neurological disorders, including Parkinson’s disease (PD) and Alzheimer’s disease (AD) development. This evidence concerns the gene TMEM230 and Parkinson disease.